__timestamp | BioMarin Pharmaceutical Inc. | Catalyst Pharmaceuticals, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 461543000 | 10117774 |
Thursday, January 1, 2015 | 634806000 | 11801342 |
Friday, January 1, 2016 | 661905000 | 11369941 |
Sunday, January 1, 2017 | 610753000 | 11375237 |
Monday, January 1, 2018 | 696328000 | 19919204 |
Tuesday, January 1, 2019 | 715007000 | 18842752 |
Wednesday, January 1, 2020 | 628116000 | 16496715 |
Friday, January 1, 2021 | 628793000 | 16936000 |
Saturday, January 1, 2022 | 649606000 | 19789000 |
Sunday, January 1, 2023 | 746773000 | 93150000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, BioMarin Pharmaceutical Inc. has consistently outpaced Catalyst Pharmaceuticals, Inc. in R&D investment. From 2014 to 2023, BioMarin's R&D expenses surged by approximately 62%, peaking at $747 million in 2023. In contrast, Catalyst Pharmaceuticals saw a more modest increase, with R&D spending reaching $93 million in 2023, a significant jump from previous years but still a fraction of BioMarin's budget.
This disparity highlights BioMarin's aggressive pursuit of new treatments and therapies, positioning it as a leader in the biotech sector. Meanwhile, Catalyst's recent uptick in spending suggests a strategic shift towards innovation. As these companies continue to invest in R&D, the pharmaceutical landscape is poised for exciting developments.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Novartis AG vs BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Catalyst Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Research and Development Investment: Exelixis, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Catalyst Pharmaceuticals, Inc. Allocate Funds
Vericel Corporation or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Catalyst Pharmaceuticals, Inc. and Novavax, Inc. Allocate Funds